Clinical Trial Update: Intrathecal Transplantation Of Autologous Adipose Tissue Derived MSC in the Patients With Spinal Cord Injury [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating intrathecal transplantation of autologous adipose tissue-derived mesenchymal stem cells in spinal cord injury has completed,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• Autologous adipose tissue-derived mesenchymal stem cells (mesenchymal stem cells (autologous adipose tissue-derived))

Snippet

Sponsor: Bukwang Pharmaceutical | Conditions: Spinal Cord Injury | Phase 1 | Status: COMPLETED